Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Gastroenterology · Ampullary cancer

Can Ampullary Cancer Be Misdiagnosed as Gallstones?

At a Glance

Ampullary cancer can be mistaken for gallstones or benign bile duct strictures because all can block bile flow and cause jaundice, pain, and abnormal liver tests. Doctors often combine imaging, endoscopy, and targeted or repeat biopsies, because one negative biopsy may not rule out cancer.

Yes, ampullary cancer can initially be misdiagnosed as, or confused with, benign (non-cancerous) conditions like gallstones, inflammatory strictures, or sphincter of Oddi dysfunction [1]. Because all of these conditions can block the common bile duct, they share many of the same symptoms, including jaundice (yellowing of the skin and eyes), abdominal pain, dark urine, pale stools, and abnormal liver tests [2]. However, doctors use a combination of advanced imaging, direct endoscopic visualization, and targeted biopsies to determine whether a blockage is caused by a benign issue or a malignant tumor.

Urgent Warning: Regardless of the underlying cause, a blocked bile duct can lead to a severe infection called acute cholangitis. If you experience jaundice accompanied by fever, chills, worsening right-upper-abdominal pain, confusion, fainting, or marked weakness, seek emergency medical care immediately [1]. Do not wait for a scheduled appointment or biopsy.

Common Benign Mimickers

When you present with a blocked bile duct, your medical team will consider several non-cancerous causes:

  • Gallstones (Choledocholithiasis): A gallstone that escapes the gallbladder and gets lodged in the bile duct can cause severe pain, jaundice, and infection [1]. Standard imaging tests like ultrasound can sometimes miss them, and stones can also coexist with a tumor [3].
  • Inflammatory Strictures: Conditions like IgG4-related disease or autoimmune pancreatitis can cause severe scarring and narrowing (strictures) in the bile duct, mimicking the appearance of a tumor [4]. Diagnosing these requires a careful correlation of imaging, tissue biopsy, and blood tests—though serum IgG4 levels can sometimes be normal, making it a complex diagnosis that should not be assumed without thorough evaluation [5].
  • Sphincter of Oddi Dysfunction: The sphincter of Oddi is the muscle valve controlling the flow of digestive juices. Dysfunction here can involve either a functional motility (movement) disorder or a fibrotic (scarred) stricture [6]. While it often causes biliary pain (especially in patients who previously had their gallbladder removed), objective signs like progressive jaundice, duct dilation, or a physical mass require thorough investigation for structural disease like cancer, rather than simply attributing symptoms to a sphincter disorder [7].

How Doctors Investigate the Blockage

To understand the cause of the blockage, doctors use several complementary tests:

  • Non-Invasive Imaging: Initial tests usually include an ultrasound or a contrast-enhanced CT scan. If the cause remains unclear, an MRI/MRCP (Magnetic Resonance Cholangiopancreatography) is often used, which provides highly detailed, non-invasive images of the bile and pancreatic ducts [8].
  • Endoscopic Ultrasound (EUS): An ultrasound probe attached to an endoscope provides high-resolution images from inside your digestive tract. It is excellent for spotting hidden gallstones, evaluating the size of an ampullary tumor, and checking local lymph nodes [3].
  • ERCP (Endoscopic Retrograde Cholangiopancreatography): This uses a side-viewing camera to directly look at the ampulla. ERCP is primarily used to relieve blockages (like placing a stent or removing a stone) and to take targeted surface biopsies [9]. However, ERCP carries risks, including pancreatitis, bleeding, and infection, so its use is carefully considered [10].
  • Cholangioscopy: In complex cases, a tiny camera is advanced directly into the bile duct to visually inspect the stricture and take targeted biopsies with high precision [11].

The Challenge of Biopsies

While a tissue biopsy is highly valuable, diagnosing ampullary cancer can be surprisingly tricky:

  • False Negatives are Common: An initial forceps biopsy taken during an ERCP misses ampullary cancer in a significant number of cases (with some studies showing missing up to 80% of malignancies depending on the tumor type and sampling method) [12].
  • Why Biopsies Miss Cancer: Tumors often grow deep beneath the surface (submucosal), leaving the top layer of tissue looking normal. Additionally, a passing gallstone or a previous ERCP can cause intense inflammation of the ampulla (papillitis), which can obscure cancer cells from the biopsy forceps [13].

Because of these limitations, a single negative or “inflammatory” biopsy does not definitively rule out cancer [13].

What If the Biopsy is Negative but Suspicion Remains?

If your symptoms or imaging strongly suggest cancer but your biopsy does not, your case should be reviewed by an experienced hepatopancreatobiliary (HPB) multidisciplinary team. There is no single “standard” next step; rather, the team will tailor a plan based on your specific situation:

  • Repeat Sampling: They might wait for acute inflammation to resolve and perform a repeat ERCP and biopsy [13].
  • Deep Needle Biopsy: Sometimes, an EUS is used to guide a needle deeper into the tissue (EUS-FNA or FNB). However, this is decided on a case-by-case basis, as the diagnostic yield can vary and there is a theoretical risk of seeding cancer cells along the needle tract for certain tumors [14].
  • Proceeding to Surgery: A definitive preoperative biopsy is not strictly required in all cases. If a lesion is highly suspicious and appears resectable, the surgical team may recommend proceeding directly to an operation (such as a Whipple procedure) [15]. During surgery, pathologists can examine rapid frozen sections to help guide the operation, though the final, definitive diagnosis will come from a detailed examination of the permanent tissue sections days later [16].

Common questions in this guide

Can gallstones cause the same symptoms as ampullary cancer?
Yes. Both gallstones in the common bile duct and ampullary cancer can block bile flow and cause jaundice, abdominal pain, dark urine, pale stools, and abnormal liver tests. A gallstone can also be present at the same time as a tumor, so finding a stone does not always exclude cancer.
Does a negative biopsy rule out ampullary cancer?
No. A surface biopsy can miss ampullary cancer when the tumor grows deeper than the tissue sampled or when inflammation hides abnormal cells. If imaging, symptoms, or a visible lesion remain concerning, one benign or inflammatory biopsy may not be enough to rule out cancer.
What tests help distinguish ampullary cancer from a benign bile duct blockage?
Doctors may combine ultrasound or contrast CT with MRI/MRCP, endoscopic ultrasound, and ERCP, a procedure that allows them to view the ampulla and take samples. These tests can show the ducts, identify stones or a mass, and assess nearby lymph nodes. Cholangioscopy may be considered when a stricture remains difficult to explain.
What happens if my biopsy is benign but doctors still suspect ampullary cancer?
An experienced hepatopancreatobiliary (HPB) team—specialists in the liver, pancreas, and bile ducts—may review the case and choose the next step based on the imaging, symptoms, and surgical options. Possibilities include repeating the biopsy after inflammation settles, using a deeper ultrasound-guided sample in selected cases, or proceeding to surgery if a suspicious lesion appears removable. There is no single next step for every patient.
When is a blocked bile duct an emergency?
Jaundice with fever, chills, worsening pain in the upper right abdomen, confusion, fainting, or marked weakness can signal acute cholangitis, a serious infection of the bile ducts. Seek emergency medical care immediately rather than waiting for a scheduled appointment or biopsy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If my biopsy showed benign or inflammatory tissue, how confident are you that we have ruled out cancer given the limitations of initial biopsies?
  2. 2.Has my case been reviewed by a multidisciplinary hepatopancreatobiliary (HPB) team to determine the best next steps?
  3. 3.Are there signs on my imaging—like both ducts being dilated or suspicious lymph nodes—that point toward a structural tumor rather than a passing gallstone or sphincter disorder?
  4. 4.What are the risks (such as pancreatitis or infection) of repeating an ERCP for another biopsy versus proceeding with other diagnostic methods?
  5. 5.If a condition like IgG4-related disease is suspected, what specific blood tests and imaging criteria are we using to confirm it before considering a steroid trial?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    FLUCTUATING JAUNDICE IN THE ADENOCARCINOMA OF THE AMPULLA OF VATER: a classic sign or an exception?

    Alves JR, Amico EC, Souza DL, et al.

    Arquivos de gastroenterologia 2015; (52(2)):147-51.

    PMID: 26039835
  2. 2

    De novo Choledocholithiasis in Retained Common Bile Duct Stent.

    Upwanshi MH, Shaikh ST, Ghetla SR, Shetty TS

    Journal of clinical and diagnostic research : JCDR 2015; (9(9)):PD17-8 doi:10.7860/JCDR/2015/13889.6478.

    PMID: 26500952
  3. 3

    Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones.

    Giljaca V, Gurusamy KS, Takwoingi Y, et al.

    The Cochrane database of systematic reviews 2015; CD011549 doi:10.1002/14651858.CD011549.

    PMID: 25719224
  4. 4

    Autoimmune Pancreatitis Type 2: Diagnostic Utility of PD-L1 Immunohistochemistry.

    Gupta R, Neyaz A, Chougule A, et al.

    The American journal of surgical pathology 2019; (43(7)):898-906 doi:10.1097/PAS.0000000000001282.

    PMID: 31135488
  5. 5

    IgG4-Related Kidney Disease and IgG4-Related Retroperitoneal Fibrosis: An Update on Diagnosis and Treatment.

    El-Feghi M, Cornell LD, Geldenhuys L, et al.

    Kidney international reports 2026; (11(8)):106630 doi:10.1016/j.ekir.2026.106630.

    PMID: 42440422
  6. 6

    Sphincter of Oddi dysfunction.

    Boivineau G, Gonzalez JM, Gasmi M, et al.

    Journal of visceral surgery 2022; (159(1S)):S16-S21 doi:10.1016/j.jviscsurg.2022.01.008.

    PMID: 35131149
  7. 7

    Gallbladder Dysfunction: Cholecystitis, Choledocholithiasis, Cholangitis, and Biliary Dyskinesia.

    Wilkins T, Agabin E, Varghese J, Talukder A

    Primary care 2017; (44(4)):575-597 doi:10.1016/j.pop.2017.07.002.

    PMID: 29132521
  8. 8

    Diagnostic Yield of Endoscopic Ultrasound in Common Bile Duct Dilation: A Real Breakthrough.

    Ferreira AI, Xavier S, Dias de Castro F, et al.

    Digestive diseases and sciences 2024; (69(11)):4275-4282 doi:10.1007/s10620-024-08628-x.

    PMID: 39342067
  9. 9

    Isolated Psoas Muscle Metastasis From Ampullary Carcinoma: A Report of a Rare Case.

    Viveiros F, Monteiro N, Monteiro C, et al.

    Cureus 2026; (18(5)):e109472 doi:10.7759/cureus.109472.

    PMID: 42338848
  10. 10

    Readmission rate and complications following biopsy of the ampulla of Vater-A retrospective data analysis.

    Rosella S, Zorron Cheng Tao Pu L, Ng J, et al.

    JGH open : an open access journal of gastroenterology and hepatology 2023; (7(4)):299-304 doi:10.1002/jgh3.12895.

    PMID: 37125251
  11. 11

    A comparative study on the application of different endoscopic diagnostic methods in the differential diagnosis of benign and malignant bile duct strictures.

    Zhu L, Huang ZQ, Wang ZW, et al.

    Frontiers in medicine 2023; (10()):1143978 doi:10.3389/fmed.2023.1143978.

    PMID: 37521338
  12. 12

    Diagnostic accuracy of cross-sectional and endoscopic imaging in ampullary tumours: systematic review.

    de Wilde AJ, de Jong EJM, Gurusamy KS, et al.

    The British journal of surgery 2024; (111(1)) doi:10.1093/bjs/znad432.

    PMID: 38198159
  13. 13

    Diagnostic Accuracy of the Initial Endoscopy for Ampullary Tumors.

    Lee HS, Jang JS, Lee S, et al.

    Clinical endoscopy 2015; (48(3)):239-46 doi:10.5946/ce.2015.48.3.239.

    PMID: 26064825
  14. 14

    Endoscopic Ultrasound Plus Endoscopic Retrograde Cholangiopancreatography Based Tissue Sampling for Diagnosis of Proximal and Distal Biliary Stenosis Due to Cholangiocarcinoma: Results from a Retrospective Single-Center Study.

    Troncone E, Gadaleta F, Paoluzi OA, et al.

    Cancers 2022; (14(7)) doi:10.3390/cancers14071730.

    PMID: 35406502
  15. 15

    Adenomatous neoplasia in the papilla of Vater endoscopic and/or surgical resection?

    Haraldsson E, Halimi A, Rangelova E, et al.

    Surgical endoscopy 2022; (36(4)):2401-2411 doi:10.1007/s00464-021-08521-y.

    PMID: 33942182
  16. 16

    Surgical method choice and coincidence rate of pathological diagnoses in transduodenal ampullectomy: A retrospective case series study and review of the literature.

    Liu F, Cheng JL, Cui J, et al.

    World journal of clinical cases 2019; (7(6)):717-726 doi:10.12998/wjcc.v7.i6.717.

    PMID: 30968036

This page explains how ampullary cancer can resemble benign bile duct problems for informational purposes only and does not constitute medical advice. Your treating team should interpret your scans and biopsies; seek emergency care for jaundice with fever, chills, worsening pain, confusion, fainting, or marked weakness.

Get notified when new evidence is published on Carcinoma of the ampulla of Vater.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.